Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • Genmab News

    268,30 € +1,55% +4,10 €
    15:54:08 Uhr Tradegate aktualisieren | Orderbuch | Mehr Kurse »
    WKN: 565131
    ISIN: DK0010272202
    US-Symbol: GNMSF
    Typ: Aktie

    Genmab News

    03.04.24 - Der Aktionär
    Übernahme! Nächster Milliarden‑Deal im Biotech‑Sektor
    16.01.23 - Wikifolio
    Die heißesten Aktien der letzten Woche
    Besonders heiß war letzte Woche die Wasserstoff-​Aktie Plug Power. Bei Tesla nahmen wikifolio Trader hingegen lieber Gewinne mit. Welche Aktien sonst noch viel gehandelt ...
    10.08.22 - PLX
    Genmab Earnings Top Expectations; Guidance Already Raised on Monday
    (PLX AI) – Genmab half year EBIT DKK 1,761 million vs. estimate DKK 1,700 million. • EBIT guidance DKK 3,800-5,400 million
    08.08.22 - PLX
    Genmab Raises Outlook for Both Revenue, Operating Profit
    (PLX AI) – Genmab new Outlook FY revenue DKK 12,000-13,000 million. • Outlook FY EBIT DKK 3,800-5,400 million
    30.06.22 - PLX
    Genmab to Submit FDA Biologics License for Epcoritamab
    (PLX AI) – Genmab to Submit Biologics License Application to U.S. Food and Drug Administration for Epcoritamab (DuoBody®-CD3xCD20) for the Treatment of Relapsed/Refractory ...
    09.06.22 - PLX
    Genmab Starts New Arbitration on Darzalex, Seeks $405 Million Plus Interest
    (PLX AI) – Genmab Commences New Arbitration Under License Agreement With Janssen. • Genmab seeking an award of $405 million plus interest in accrued milestone payments ...
    11.05.22 - PLX
    Genmab Q1 Earnings Beat Expectations; Raises Lower End of Guidance Range
    (PLX AI) – Genmab Q1 EBIT DKK 514 million vs. estimate DKK 433 million. • Outlook FY revenue DKK 11,000-12,000 million • Outlook FY EBIT DKK 3,200-4,800 million • Q1 revenue ...
    19.04.22 - PLX
    Genmab Q1 Darzalex Sales $1,856 Million
    (PLX AI) – Genmab reports net sales of DARZALEX in the first quarter of 2022 totaled USD 1,856 million. • Net trade sales were USD 953 million in the U.S. and USD 903 million in the ...
    08.03.22 - PLX
    Genmab's Epcoritamab Gets FDA Orphan-Drug Designation in Follicular Lymphoma
    (PLX AI) – Genmab Announces U.S. Food and Drug Administration Granted Orphan-​Drug Designation to Epcoritamab (DuoBody®-CD3xCD20) in Follicular Lymphoma. • Epcoritamab ...
    24.02.22 - PLX
    Genmab, Seagen Phase 2 Trial of Tisotumab Vedoti in Neck Cancer Shows Promising Preliminary Antitumor Activity
    (PLX AI) – Genmab and Seagen give data on phase 2 trial of tisotumab vedotin (TIVDAK) as a monotherapy in patients with squamous cell carcinoma of the head and neck (SCCHN) ...
    16.02.22 - PLX
    Genmab Earnings Beat Consensus; Revenue Guidance Better Than Expected
    (PLX AI) – Genmab FY EBIT DKK 3,018 million vs. estimate DKK 2,970 million. • Outlook 2022 revenue DKK 10,800-12,000 million; consensus DKK 11,157 million • Outlook 2022 ...
    10.11.21 - PLX
    Genmab 9-Month Revenue, EBIT Top Consensus
    (PLX AI) – Genmab 9-month EBIT DKK 2,209 million vs. estimate DKK 1,966 million. • 9-month revenue DKK 5,863 million vs. estimate DKK 5,696 million • Genmab already raised ...
    05.11.21 - PLX
    Genmab Raises Full-Year Revenue Guidance by DKK 600 Million
    (PLX AI) – Genmab 2021 revenue outlook now DKK 7,900-8,500 million, up from DKK 7,300-7,900 million previously. • FY operating result outlook now DKK 2,300-3,200 million, up ...
    19.10.21 - PLX
    Genmab Q3 Darzalex Sales USD 1,580 Million
    (PLX AI) – Genmab Announces Net Sales of DARZALEX® (daratumumab) for the Third Quarter of 2021 • Genmab Net sales of DARZALEX ® in the third quarter of 2021 totaled USD ...
    20.09.21 - PLX
    Genmab Says FDA Granted Accelerated Approval for TIVDAK in Cervical Cancer
    (PLX AI) – Genmab and Seagen Announce FDA Accelerated Approval for TIVDAK (tisotumab vedotin-​tftv) in Previously Treated Recurrent or Metastatic Cervical Cancer. • TIVDAK is a ...
    11.08.21 - PLX
    Genmab Raises Guidance After H1 Earnings Beat Consensus
    (PLX AI) – Genmab half year EBIT DKK 1,319 million vs. estimate DKK 880 million • half year revenue DKK 3,553 million vs. estimate DKK 3,251 million • Outlook FY revenue DKK ...
    21.07.21 - PLX
    Genmab Q2 Darzalex Sales USD 1,433 Million
    (PLX AI) – Genmab Net sales of DARZALEX in the second quarter of 2021 totaled USD 1,433 million. • Net trade sales were USD 770 million in the U.S. and USD 663 million in the ...
    14.12.20 - echtgeldTV
    Genmab | echtgeld.tv vom 09.12.2020
    Hier seht Ihr einen Ausschnitt aus dem Programm von echtgeld.tv. In diesem Snippet sprechen Tobias Kramer und Christian W. Röhl über die Genmab Aktie (WKN: 565131) aus ...
    02.11.20 - echtgeldTV
    Genmab | echtgeld.tv vom 28.10.20
    Hier seht Ihr einen Ausschnitt aus dem Programm von echtgeld.tv. In diesem Snippet sprechen Tobias Kramer und Christian W. Röhl über die Genmab Aktie (WKN: 565131) aus ...
    31.10.20 - The Motley Fool
    Biontech-Aktie: Wie das Unternehmen die Krebsmedizin revolutionieren könnte!
    Biontech (WKN: A2PSR2) steht derzeit vor allem aufgrund seines neuartigen mRNA-​Covid-19-Impfstoffes im Rampenlicht , der bisher scheinbar alle Entwicklungsphasen ...

    Newssuche

    Videos

    newspaper
    18.04.24
    Technical Trading: Gold mit weiterem Potenzial
    Gold Long Typ: Turbo Open End WKN: UH4MU6 Hebel: 4,67 Laufzeit: OpenEnd Einstieg: Market ... Mehr »